eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Letters

HIV among injecting drug users of Indo-Chinese ethnicity in Victoria

Jane S Hocking, Peter G Higgs, Cathy M Keenan and Nick Crofts
MJA 2002; 176 (4): 191-192

To the Editor: Australia has been successful so far in maintaining a low prevalence of HIV infection among injecting drug users (IDUs). This has been achieved by adopting a harm-reduction approach to the prevention of bloodborne virus transmission, including needle and syringe programs, methadone maintenance and peer-education. Sharing of needles and syringes has declined markedly: cross-sectional surveys among users of needle and syringe programs across Australia have shown a decrease in the prevalence of reported sharing from 31% in 1995 to 15% in 1997.1

However, there is evidence that among some subpopulations, especially those of Indo-Chinese origin, unsafe injecting practices remain common. In a survey of Indo-Chinese IDUs in Sydney and Melbourne, Maher et al reported that 22% of those surveyed had shared needles and syringes in the preceding month.1 Although the Indo-Chinese community is becoming increasingly aware of issues related to drug use, IDUs are under-represented in drug treatment programs.3 There is also evidence that parents send their children back to their country of origin to escape the Australian heroin scene. In a Melbourne survey of Vietnamese IDUs, Kelsall et al reported that 19% of their sample (38 of 200) had returned to Vietnam during the previous five years for drug-related reasons. Of these, 24 reported using heroin in Vietnam, a disturbing finding given that HIV prevalence among IDUs in parts of Vietnam is greater than 50%.4

We analysed HIV surveillance data in Victoria to investigate whether there was an over-representation of Indo-Chinese-born IDUs. Country of birth has been collected as part of HIV notification in Victoria since January 1996. Since then, there have been 38 notifications of HIV infection in individuals reporting intravenous drug use as a risk factor. Of these 38, 11 (29%; 95% CI, 15%–46%) reported an Indo-Chinese country of birth — a higher proportion than expected given the 1996 census finding that 1.5% of Victoria's population was born in an Indo-Chinese country.5 These 11, all men, were significantly younger than other IDUs notified in this time (mean, 23.3 years v 31.3 years, respectively; P < 0.05).

Although these numbers are small, they highlight a group at increased risk of HIV who are not currently being effectively reached by prevention services. These data also suggest a hidden route for spread of HIV from Asia into the Australian community. There is an urgent need to provide culturally relevant education and harm-reduction programs to prevent transmission of HIV within this group. The Victorian Department of Human Services is allocating additional resources to working with culturally and linguistically diverse communities on prevention activities to address this issue.

  1. MacDonald MA, Wodak AD, Dolan KA, et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Med J Aust 2000; 172: 57-61. <eMJA full text> <PubMed>
  2. Maher L, Sargent P, Higgs P, et al. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne. Aust N Z J Public Health 2001; 25: 50-54. <PubMed>
  3. Reid G, Crofts N, Beyer L. Drug treatment services for ethnic communities in Victoria, Australia: an examination of cultural and institutional barriers. Ethn Health 2001; 6: 13-26. <PubMed>
  4. Kelsall J, Higgs P, Crofts N. The Vietnamese Harm Reduction Project: Stage 2. Melbourne: Centre for Harm Reduction, Macfarlane Burnet Centre for Medical Research, 2001.
  5. Australian Bureau of Statistics. 1996 census of population and housing. Canberra: AGPS, 1997.

Acknowledgements: We gratefully acknowledge the efforts of Tom Carter, Beth Hatch and Jane Tomnay of the Victorian Department of Human Services in collecting additional HIV notification information. Thanks also to Lisa Maher and Margaret MacDonald for their assistance in providing additional information. Jane Hocking and Cathy Keenan were supported by the Victorian Health Promotion Foundation.

(Received 5 Oct 2001, accepted 19 Nov 2001)

Macfarlane Burnet Centre for Medical Research, Fairfield, VIC.

Jane S Hocking, MPH, MHlthSc, Senior Research Officer; Peter G Higgs, BSW, MA, Senior Research Officer; Cathy M Keenan, BAppSc, MAppEpi, Senior Research Officer; Nick Crofts, MBBS, FAFPHM, Deputy Director.

Correspondence: Ms Jane S Hocking, Macfarlane Burnet Centre for Medical Research, PO Box 254, Fairfield, VIC 3078. hockingATburnet.edu.au

AntiSpam note: To avoid spam, authors' email addresses are written with AT in place of the usual symbol, and we have removed "mail to" links. Replace AT with the correct symbol to get a valid address.

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2002 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377